Vol. 28.S1 March 2023 | Annals of Hepatology

Abstracts of the 2022 Annual Meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)

Ann Hepatol. 2023;28 Supl 1:100904

Full text access

Ann Hepatol. 2023;28 Supl 1:101095

Full text access

P1- HIGH VIRAL SUPPRESSION AND IMPROVED SAFETY PROFILE OF TENOFOVIR ALAFENAMIDE RELATIVE TO TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B PATIENTS TREATED FOR 5 YEARS

Wai Kay Seto, Ting-Tsung Chang, Abhijit Chowdhry, Chi-Yi Chen, Mustafa Kemal Celen, Xiaoli Ma, Mang Ma, Ajay Duseja, ... Edward J. Gane

Ann Hepatol. 2023;28 Supl 1:100904.1

Full text access

P-2 DE NOVO LIPOGENESIS MARKERS ARE INVOLVED IN METABOLIC ASSOCIATED FATTY LIVER DISEASE PROGRESSION IN BTBR OB/OB MICE

Lucas Opazo-Rios, Manuel Soto-Catalan, Iolanda Lázaro, Aleix Sala-Vila, Cristian Pérez-Gallardo, Fabian Segovia-Miranda, Juan Antonio Moreno, Jesús Egido, Sebastián Mas-Fontao

Ann Hepatol. 2023;28 Supl 1:100904.2

Full text access

P-3 PLASMA EXCHANGE WITH ALBUMIN INCREASES EFFECTIVE ALBUMIN LEVELS IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE

Raquel Horrillo, Anna Mestre, Alba Pérez, Jordi Vidal, Estefania Alcaraz, Mireia Torres, Vicente Arroyo, Javier Fernández, ... Montserrat Costa

Ann Hepatol. 2023;28 Supl 1:100904.3

Full text access

P-4 RISK OF HCC IN SOUTH AMERICANS ASSOCIATED WITH TLL1 VARIANT SINGLE NUCLEOTIDE POLYMORPHISM

Andre Boonstra, Domingo Balderramo, Dhamina Karim, Jhon Prieto Ortiz, Javier Diaz Ferrer, Angelo Mattos, Marcos Arrese Jimenez, Enrique Carrera Estupinan, ... Jose Debes

Ann Hepatol. 2023;28 Supl 1:100904.4

Full text access

P-5 THREE-DIMENSIONAL SINGLE-CELL ATLAS OF LIVER TISSUE ARCHITECTURE

Dilan Martinez, Maldonado Valentina, Cristian Perez, Valeria Candia, Hernán Morales-Navarrete, Fabián Segovia-Miranda

Ann Hepatol. 2023;28 Supl 1:100904.5

Full text access

P-6 PATTERNS OF ANTIBIOTIC RESISTANCE IN PATIENTS WITH CIRRHOSIS AND SPONTANEOUS BACTERIAL INFECTIONS: ANALYSES OF THE MULTICENTER STUDY FROM ARGENTINA AND URUGUAY

Sebastián Marciano, Maria Nelly Gutierrez Acevedo, Sabrina Barbero, Lorena del Carmen Notari, Marina Agozino, Jose Luis Fernandez, Maria Margarita Anders, Nadia Grigera, ... Adrian Gadano

Ann Hepatol. 2023;28 Supl 1:100904.6

Full text access

P-7 LIVER INJURY AFTER COVID-19 VACCINATION COMPARED TO POST-INFLUENZA VACCINES: RETROSPECTIVE COHORT STUDY

Marlene Padilla Lopez, Natalia Sobenko, Valeria Ines Aliperti, Vanina Cecilia Stanek, Maria Florencia Grande Ratti, Fernando Ezequiel Jabif, Marcelo Gabriel Vallone, Alejandra Villamil

Ann Hepatol. 2023;28 Supl 1:100904.7

Full text access

P-8 EXTRACELLULAR VESICLE-DERIVED MICRORNA SIGNATURE IN HCV AND HCV/HIV PATIENTS WITH DIFFERENT STAGES OF LIVER FIBROSIS

Victoria Cairoli, Daniel Valle Millares, Pablo Ryan, Lourdes Dominguez, Luz Martín-Carbonero, Beatriz Ameigeiras, Verónica Briz, Amanda Fernandez Rodriguez, ... Pamela Valva

Ann Hepatol. 2023;28 Supl 1:100904.8

Full text access

P- 9 BIOMARKERS OF THE BACTERIAL, VIRAL AND HUMAN GUT TRANSCRIPTOME IN METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN ARGENTINA

María Florencia Mascardi, Flavia Noelia Mazzini, Bárbara Suárez, Vera M. Ruda, Sebastián Marciano, Paola Casciato, Adrián Narvaez, Leila Haddad, ... Julieta Trinks

Ann Hepatol. 2023;28 Supl 1:100904.9

Full text access

P-10 PATTERNS OF PROGRESSION AND TREATMENT DISCONTINUATION IN A REAL LIFE LATIN AMERICAN PROSPECTIVE COHORT STUDY OF INTERMEDIATE-ADVANCED HEPATOCELLULAR CARCINOMA: SECOND INTERIM ANALYSIS

Federico Piñero, Margarita Anders, Carla Bermudez, Ezequiel Demirdjian, Adriana Varón, Ana Palazzo, Jorge Rodriguez, Oscar Beltrán, ... Manuel Mendizabal

Ann Hepatol. 2023;28 Supl 1:100904.10

Full text access

P- 11 PROTUMORIGENIC GALECTINS 1 AND 3 ARE UPREGULATED IN THE LIVER OF MICE EXPOSED TO CONTINUOUS GROWTH HORMONE LEVELS

Santiago De La Fuente, Verónica Gabriela Piazza, Nadia Sofía Cicconi, María Lorena Bacigalupo, Luciana Sarrias, Ana Isabel Sotelo, Andrzej Bartke, María Fernanda Troncoso, Johanna Gabriela Miquet

Ann Hepatol. 2023;28 Supl 1:100904.11

Full text access

P- 12 PATHOGENIC VARIANT OF PNPLA3 DOES NOT ASSOCIATE WITH HEPATOCELLULAR CARCINOMA IN SOUTH AMERICANS. A REPORT FROM THE ESCALON NETWORK

Domingo Balderramo, Joshep Akambase, Jhon Prieto Ortiz, Javier Diaz Ferrer, Angelo Mattos, Marcos Arrese Jimenez, Enrique Carrera Estupinan, Zwier Groothuismink, ... Jose Debes

Ann Hepatol. 2023;28 Supl 1:100904.12

Full text access

P-13 PREVALENCE, CHARACTERIZATION, AND SURVIVAL OF ACUTE ON CHRONIC LIVER FAILURE IN A LATIN AMERICAN COHORT: A MULTICENTER STUDY

Francisco Idalsoaga, Luis Antonio Díaz, Gustavo Ayares, Jorge Arnold, Víctor Meza, Franco Manzur, Joaquín Sotomayor, Hernán Rodríguez, ... Juan Pablo Arab

Ann Hepatol. 2023;28 Supl 1:100904.13

Full text access

P-14 OPTIMIZATION OF MOLECULAR METHODS FOR SARS-CoV-2 QUALITATIVE DETECTION AND GENOTYPING IN RESPIRATORY SPECIMENS FROM PATIENTS WITH LIVER DISEASE

Vanessa Duarte da Costa, Alanna Calheiros Santos, Lucas Limas da Silva, Wilian Jean Wiggers, Claudia Alexandra Pontes Ivantes, Danielle Malta Lima, Jeová Keny Baima Colares, Deusilene Souza Vieira Dallacqua, ... Livia Melo Villar

Ann Hepatol. 2023;28 Supl 1:100904.14

Full text access

P-15 MMP-2 AND MMP-9 LEVELS IN ALCOHOLIC LIVER DISEASE, NON-ALCOHOLIC FATTY LIVER DISEASE AND CHRONIC HEPATITIS C

María Lemus-Peña, Abigail Hernandez-Barragan, Daniel Montes de Oca-Ángeles, Marisela Hernandez-Santillan, Daniel Santana-Vargas, Moisés Martinez-Castillo, Zaira Medina-Avila, Aldo Torre-Delgadillo, ... Gabriela Gutiérrez-Reyes

Ann Hepatol. 2023;28 Supl 1:100904.15

Full text access

P-16 FIRST MICRO ELIMINATION INTERVENTION OF HEPATITIS B &C IN INMATES OF THE EIGHT PRISONS IN THE PROVINCE OF MENDOZA, ARGENTINA

Gabriela Villar, Laura Rolla, Laila Hadid, Vanina Padovani, A Massutti, Diego Terraza, Hector Cuello, Roberto Perez Ravier, ... Carlos Espul

Ann Hepatol. 2023;28 Supl 1:100904.16

Full text access

P- 17 FRAILTY AND COVERT HEPATIC ENCEPHALOPATHY IN CIRRHOTIC PATIENTS AT A THIRD LEVEL HOSPITAL IN GUATEMALA

Katherine Maldonado, Abel Sánchez

Ann Hepatol. 2023;28 Supl 1:100904.17

Full text access

P- 18 TREATMENT WITH BEVACIZUMAB IN HIGH OUTPUT CARDIAC FAILURE DUE TO SEVERE HEPATIC COMPROMISE IN HEREDITARY HEMORRHAGIC TELANGIECTASIA PATIENTS: OBSERVATIONAL COHORT STUDY

Carolina Vazquez, Juan Bandi, Marcelo Serra

Ann Hepatol. 2023;28 Supl 1:100904.18

Full text access

P-19 SPLENIC IRON OVERLOAD IN PATIENTS WITH HEREDITARY HEMOCHROMATOSIS

Maria Florencia Yamasato, Mariano Volpacchio, María Alejandra Avagnina, Enzo Rey, Alejandra Vellicce, Esteban Gonzalez Ballerga, Juan Antonio Sordá, Jorge Daruich

Ann Hepatol. 2023;28 Supl 1:100904.19

Full text access

P- 21 DOCOSAHEXAENOIC ACID AND ITS DERIVATIVE MARESIN1 IMPROVE CHRONIC LIVER DAMAGE ASSOCIATED WITH THE PROMOTION OF APOPTOSIS PATHWAYS AND LIVER REGENERATION IN A SPRAGUE-DAWLEY MODEL.

Jessica Zúñiga-Hernández, Francisca Herrera Vielma, Matías Quiñones, María José Zúñiga

Ann Hepatol. 2023;28 Supl 1:100904.20

Full text access

P-23 TEST AND TREAT: PROFILE OF PATIENTS DIAGNOSED WITH HEPATITIS C IN THE PRISON SYSTEM OF PORTO ALEGRE, BRAZIL

Eduardo Emerim, Viviane De Lima Cezar, Elenita Majaro Pinto Ferreira, Ana Francisca Perinazzo Fontoura, Daniel Conte Herter, Roslaine Ifran Amaral, João Nagildo, Rafael De Oliveira Nogueira, ... Pauline Soares Ferrugem

Ann Hepatol. 2023;28 Supl 1:100904.21

Full text access

P- 24 RISK OF MULTIPLE DRUG INTERACTIONS POTENTIALLY LINKED TO SAFETY IN PATIENTS RECEIVING PANGENOTYPIC DIRECT-ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C

Juan Turnes, Antonio García-Herola, Ramón Morillo, Marinela Méndez, Magdalena Rueda, Cándido Hernández, Antoni Sicras-Mainar, Jorge Mendez-Navarro

Ann Hepatol. 2023;28 Supl 1:100904.22

Full text access

P- 25 ANTIOXIDANT EFFECT OF MORINGA OLEIFERA IN A MURINE MODEL OF NONALCOHOLIC STEATOHEPATITIS

Alejandra Monraz-Méndez, Raymundo Escutia-Gutiérrez, Jonathan Rodríguez-Sanabria, Ricardo De la Rosa-Bibiano, Laura Sánchez-Orozco, Arturo Santos, Juan Armendáriz-Borunda, Ana Sandoval-Rodríguez

Ann Hepatol. 2023;28 Supl 1:100904.23

Full text access

P- 26 EFFECT OF PROTEIN X OF THE HEPATITIS B VIRUS AND HEXACHLOROBENZENE ON LIVER CELL GROWTH DYSREGULATION

Zahira Deza, Verónica Mathet, Lucia Coli, José Oubiña, Laura Alvarez, Ezequiel Ridruejo

Ann Hepatol. 2023;28 Supl 1:100904.24

Full text access

P-27 CELLULAR EFFECTS OF IN VITRO LIPID OVERLOAD ON HEPATIC STELLATE CELLS AND HEPATOCYTES.

Adriana Campos-Espinosa, José Luis Pérez-Hernández, Gabriela Gutiérrez-Reyes, Carolina Guzmán

Ann Hepatol. 2023;28 Supl 1:100904.25

Full text access

P- 28 ATORVASTATIN SHOWS ANTI-PROMOTOR AND ANTI-NEOANGIOGENIC EFFECT IN HEPATOCELLULAR CARCINOMA DEVELOPMENT IN VIVO AND IN VITRO MODEL BY INHIBITING TGF-β1/pERK SIGNALING PATHWAY

Ezequiel Ridruejo, Zahira Deza, Giselle Romero Caimi, Lucia Coli, AndLaura Alvarez

Ann Hepatol. 2023;28 Supl 1:100904.26

Full text access

P-29 THE LIVER IN AMYLOIDOSIS: AN ANALYSIS OF THE INSTITUTIONAL AMYLOIDOSIS REGISTRY

María Adela Aguirre, Marcelina Carretero, Eugenia Villanueva, Elsa Mercedes Nucifora, María Soledad Saez, Erika Bárbara Brulc, Diego Pérez De Arenaza, Sebastián Marciano, ... María Lourdes Posadas Martínez

Ann Hepatol. 2023;28 Supl 1:100904.27

Full text access

P- 30 CLINICAL FEATURES, TREATMENT, AND SURVIVAL OF PATIENTS WITH BUDD-CHIARI SYNDROME IN A HEPATOLOGY COLOMBIAN CENTER

Ximena Morales, Daniel Rojas, Felipe Durán-Torres, Carolina Salinas, Leonardo Pérez, Andrés Murillo, Enrique Ponce, Jorge Ceballos, ... Oscar Beltrán

Ann Hepatol. 2023;28 Supl 1:100904.28

Full text access

P-31 SHORT-TERM EFFICACY AND SAFETY OF LOLA THERAPY IN PATIENTS WITH CIRRHOSIS AND MINIMAL HEPATIC ENCEPHALOPATHY: A REAL-LIFE COHORT STUDY

Fátima Higuera-De La Tijera, AB Moreno-Cobos, Christian Hinojosa-Segura, Diana Montemira-Orozco, Imran Cruz-Reyes, Juana Zavala-Ramírez, Daniel Santana-Vargas, Alfredo Servín-Caamaño, ... José Luis Pérez-Hernández

Ann Hepatol. 2023;28 Supl 1:100904.29

Full text access

P- 32 HEPATITIS A AND E VIRUSES IN CÓRDOBA, ARGENTINA: WASTEWATER-BASED EPIDEMIOLOGY AS A SILENT SENTINEL OF THE TREND OF VIRUS CIRCULATION IN THE COMMUNITY

Anabella Fantilli, Guadalupe Di Cola, Paola Sicilia, Gonzalo Castro, María De Los Ángeles Marinzalda, Ariana Cachi, Gustavo Ibarra, Laura López, ... Viviana Ré

Ann Hepatol. 2023;28 Supl 1:100904.30

Full text access

P-33 IMPACT OF SUSTAINED VIROLOGIC RESPONSE ON GLUCOSE PARAMETERS AMONG CHRONIC HEPATITIS C PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS

Hugo Cheinquer, Fabia Benetti, Alexandre de Araujo, Italo de Maman, Cristina Cheinquer Coelho Borges, Fernando Wolff Herz

Ann Hepatol. 2023;28 Supl 1:100904.31

Full text access

P- 34 HEPATOCELLULAR CARCINOMA IN CHILE; A RETROSPECTIVE MULTICENTER STUDY OF 856 PATIENTS

Blanca Norero, Gonzalo Latorre, Diego Reyes, Carlos Benitez, Rodrigo Wolff, Marco Arrese, Macarena Viñuela Morales, Matias Torres Parada, ... Rodrigo Zapata

Ann Hepatol. 2023;28 Supl 1:100904.32

Full text access

P- 35 RELINKAGE OF PATIENTS WITH CHRONIC HEPATITIS C INFECTION IN THE CONTEXT OF THE COVID-19 PANDEMIC

Gisela Fabiana Sotera, Melina Ferreiro, Margarita Martes, Cordero Nancy, Jonathan Salmon, Juan Sordá, Jorge Daruich, Esteban González Ballerga

Ann Hepatol. 2023;28 Supl 1:100904.33

Full text access

P-36 RESULTS OF AN AUTOMATIC ALERT SYSTEM FROM MICROBIOLOGY TO LINK DIAGNOSIS TO TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C

Carlos Alventosa Mateu, María Dolores Ocete Mochón, Juan José Urquijo Ponce, Mercedes Latorre Sánchez, Inmaculada Castelló Miralles, Miguel García Deltoro, Enrique Ortega González, María José Bonet Igual, ... Moisés Diago Madrid

Ann Hepatol. 2023;28 Supl 1:100904.34

Full text access

P-37 ASSESSMENT OF METABOLIC ASSOCIATED FATTY LIVER DISEASE, ALCOHOLIC LIVER DISEASE, AND DUAL DAMAGE IN APPARENTLY HEALTHY BLOOD BANK INDIVIDUALS

Jorge Emilio Lira-Vera, O Morales-Gutiérrez, Farid Yael Vargas-Durán, Pablo Alagón-Fernández Del Campo, Ana Karen Soto Martínez, Diana Montemira-Orozco, Andrés Burak-Leipuner, Christian Hinojosa-Segura, ... José Luis Pérez-Hernández

Ann Hepatol. 2023;28 Supl 1:100904.35

Full text access

P-38 CRYPTOGENIC CHRONIC HEPATITIS: LOOKING FOR AN ETIOLOGICAL DIAGNOSIS

Guilherme Cançado Grossi Lopes, Aline Candolo Coelho Rocha, Jorge Nardelli Mateus, Patricia Zitelli Momoyo, Daniel Mazo Ferraz De Campos, Claudia Oliveira Pinto Marques De Souza, Marlone Cunha-Silva, Raquel Greca Dias, ... Mário Guimarães Pessôa

Ann Hepatol. 2023;28 Supl 1:100904.36

Full text access

P- 39 CLINICAL SIGNIFICANCE OF GRADE 1 HEPATIC ENCEPHALOPATHY IN PATIENTS HOSPITALIZED FOR COMPLICATIONS OF CIRRHOSIS

Janaína Luz Narciso-Schiavon, Fernanda Cristina De Augustinho, Claudia Maccali, Esther Buzaglo Dantas-Correa, Leonardo Lucca Schiavon

Ann Hepatol. 2023;28 Supl 1:100904.37

Full text access

P-40 IS THERE A DISTINCT PHENOTYPE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN LEAN AND OVERWEIGHT PATIENTS?

Denise Siqueira Vanni, José Tadeu Stefano, Sebastião Mauro Bezerra Duarte, Patricia Momoyo Yoshiura Zitelli, Renato Gama Altikes, Karla Toda Oti, Mário Guimarães Pessoa, Flair José Carrilho, Claudia P Oliveira

Ann Hepatol. 2023;28 Supl 1:100904.38

Full text access

P-41 SARCOPENIA AS A PREDICTOR OF RISK OF MINIMAL HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER CIRRHOSIS

Oscar Morales Gutiérrez, María de Fátima Higuera de la Tijera, José Luis Pérez Hernández

Ann Hepatol. 2023;28 Supl 1:100904.39

Full text access

P-42 OBESITY AND ANTI-HBC IGG POSITIVITY INCREASE THE RISK OF HEPATOCELLULAR CARCINOMA IN A COHORT OF CHRONIC HEPATITIS C PATIENTS IN A TERTIARY OUTPATIENT CLINIC IN SÃO PAULO, BRAZIL

Alexandre Trazzi, Patricia Momoyo Zitelli, Daniel Mazo Ferraz, Roque Gabriel Rezende, Claudia Oliveira Pinto, Aline Chagas Lopes, Flair José Carrilho, Mário Guimarães Pessoa

Ann Hepatol. 2023;28 Supl 1:100904.40

Full text access

P- 43 PIRFENIDONE PREVENTS NEOPLASTIC LESIONS DEVELOPMENT BY OXIDATIVE, FIBROGENIC, ANTIPROLIFERATIVE AND EPIGENETIC MECHANISMS REGULATION IN A MODEL OF CHEMICAL HEPATOCARCINOGENESIS

Hipólito Otoniel Miranda-Roblero, Hugo Christian Monroy-Ramírez, Marina Galicia-Moreno, Ana Sandoval-Rodriguez, Arturo Santos, Juan Armendáriz-Borunda

Ann Hepatol. 2023;28 Supl 1:100904.41

Full text access

P- 44 HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS IN A PARAGUAYAN LIVER REFERENCE CENTER: CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS

Lorena Martínez, Amaya Ortiz, Rodrigo Pérez, Mirian Colarte, Sebastián Díaz, Martin Sánchez, Johana Silvero, Maisa Vallejos, ... Jesus Ortiz

Ann Hepatol. 2023;28 Supl 1:100904.42

Full text access

P- 45 ENDOSCOPIC ULTRASOUND SHEAR-WAVE ELASTOGRAPHY OF THE RIGHT AND LEFT HEPATIC LOBE PREDICTS LIVER CIRRHOSIS: A DIAGNOSTIC TRIAL

Carlos Robles-Medranda, Raquel Del Valle Zavala, Miguel Puga-Tejada, Martha Arévalo-Mora, Jorge Baquerizo-Burgos, Gabriela Egas-Izquierdo, Daniela Tabacelia, Roberto Oleas, ... Hannah Pitanga-Lukashok

Ann Hepatol. 2023;28 Supl 1:100904.43

Full text access

P-48 EVALUATION OF IL-1β AND IL-1RA IN PATIENTS WITH CHRONIC LIVER DISEASES

Abigail Hernandez-Barragan, Z. Medina-Avila, D. Montes-de-Oca-Angeles, M. Lemus-Peña, M. Hernandez-Santillan, M. Martínez-Castillo, J.L. Pérez-Hernández, F. Higuera-De la Tijera, ... G. Gutiérrez-Reyes

Ann Hepatol. 2023;28 Supl 1:100904.44

Full text access

P-49 CONCENTRATION OF IL-12 AND CXCL-10 IN CHRONIC LIVER DISEASES

Marisela Hernandez-Santillan, Moisés Martínez-Castillo, Zaira Medina-Ávila, Abigail Hernández-Barragan, María Lemus-Peña, Daniel Montes de Oca-Ángeles, José Luis Pérez-Hernández, Fátima Higuera-De la Tijera, ... Gabriela Gutiérrez-Reyes

Ann Hepatol. 2023;28 Supl 1:100904.45

Full text access

P- 50 SEROPREVALENCE OF HEPATITIS E VIRUS IN HIV-INFECTED PATIENTS FROM ROSARIO, SANTA FE

Julián Acosta, Alceo Galimberti, Federico Marziali, Fernando Bessone, Alejandro Costaguta, Damián Águila, Sergio Lupo, Bruno Rocha De Lima, ... Ana Laura Cavatorta

Ann Hepatol. 2023;28 Supl 1:100904.46

Full text access

P- 51 HEALTH EDUCATION AND SEROPREVALENCE OF HEV IN RURAL AND PERI-URBAN POPULATION, WITH AGRICULTURAL ACTIVITY IN BAHIA – BRAZIL - PRELIMINARY DATA

Fernanda Anjos Bastos, Uilza Miranda, Ramon Mendes Dos Santos, Caio Lopes Borges Andrade, Robert Schaer, Izabela Maria Del Rei Pereira Rosa, Maria Izabel Cerqueira Da Silva E Silva, Luiz Felipe Monteiro Darzé, ... Maria Isabel Schinoni

Ann Hepatol. 2023;28 Supl 1:100904.47

Full text access

P-52 MALNUTRITION IN COMPENSATED AND DECOMPENSATED LIVER CIRRHOSIS

Andrea Curia, Maria Cielo Gutierrez, Cynthia Laura Musso, Jorge Daruich, Juan Antonio Sorda, Esteban Gonzalez Ballerga

Ann Hepatol. 2023;28 Supl 1:100904.48

Full text access

P-53 HELICOBACTER PYLORI INFECTION IN PATIENTS WITH PEPTIC ULCER DISEASE AND CIRRHOSIS OF THE LIVER

Jaime Fustamante, Eduardo Monge, Claudia Soto, Julio Narroquin, Lucero Torres

Ann Hepatol. 2023;28 Supl 1:100904.49

Full text access

P- 54 HEPATITIS C MICROELIMINATION IN FORMER DRUG USERS

Fernando Gruz, Maria Gimena Fernandez, Santiago Gimenez, Guillermo Dorado, Maria Laura Martin, Adrian Farias, Solange Mizrahi, Maricel Bellicoso

Ann Hepatol. 2023;28 Supl 1:100904.50

Full text access

P 56- SHORT-TERM RESPONSE OF P300 EVOKED POTENTIAL IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY TREATED WITH L-ORNITHINE, L-ASPARTATE

José Luis Pérez-Hernández, Christian Hinojosa-Segura, Diana Montemira-Orozco, Andrés Burak-Leipuner, Juana Zavala-Ramírez, Imram Cruz-Reyes, María Escobedo-Silva, Fátima Higuera-de la Tijera, Daniel Santana-Vargas

Ann Hepatol. 2023;28 Supl 1:100904.51

Full text access

P- 57 SURVIVAL AND LIVER TRANSPLANTATION FOR PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE IN URUGUAY

Martín Elizondo, Romina Rey, Victoria Mainardi, María Clara Gouarnalusse, Marcelo Valverde, Solange Gerona

Ann Hepatol. 2023;28 Supl 1:100904.52

Full text access

P-58 PREVALENCE OF CHRONIC VIRAL HEPATITIS TYPE C IN PEOPLE DEPRIVED OF THEIR LIBERTY IN THE CERESOS OF THE STATE OF VERACRUZ, MEXICO: TOWARDS MICRO-ELIMINATION

María Teresa Guzmán Terrones, Ignacio Manuel Pérez Acosta, Mauricio Alfaro Centeno

Ann Hepatol. 2023;28 Supl 1:100904.53

Full text access

P-60 DETERMINATION OF THE PREVALENCE OF HEPATITIS C VIRUS USING THE RAPID MONTEBIO HCV TEST IN A HIGH-RISK POPULATION OF HOSPITAL DEL SALVADOR, CHILE.

Alejandro Carvajal, Carlos Valdebenito, Luis Salazar, Gonzalo Veloso, Stephany Albán, Gabriel Mezzano

Ann Hepatol. 2023;28 Supl 1:100904.54

Full text access

P-61 PREVALENCE OF HEPATITIS E VIRUS INFECTION ON CIRRHOTIC PATIENT POPULATION FROM ROSARIO

Julián Acosta, Alceo Galimberti, Federico Marziali, Fernando Bessone, Alejandro Costaguta, Hugo Tanno, Virginia Reggiardo, Daniela Gardiol, Ana Laura Cavatorta

Ann Hepatol. 2023;28 Supl 1:100904.55

Full text access

P- 62 PREDICTION OF FIBROSIS PROGRESSION AND CLINICAL OUTCOMES WITH NON INVASIVE TESTS IN 10 YEARS FOLLOW UP OF PATIENTS WITH NON ALCOHOLIC STEATOHEPATITIS

Renato Gama Altikes, Patricia Momoyo Yoshiura Zitelli, Rosa Maria Nascimento Marcusso, Denise Vanni, José Tadeu Stefano, Flair J Carrilho, Mário Guimaraes Pessoa, Claudia P Oliveira

Ann Hepatol. 2023;28 Supl 1:100904.56

Full text access

P- 63 TREATING HEPATITIS C (HCV) IN ADDICTION CENTERS IN OUR COMMUNITY: ANOTHER STEP TOWARDS MICROELIMINATION

Sonia Blanco-Sampascual, Rodrigo Oraa, Amaia Castrillo-Olabarria, Fernando Menendez-Blazquez

Ann Hepatol. 2023;28 Supl 1:100904.57

Full text access

P- 64 HEPATITIS C VIRUS MICRO-ELIMINATION PROGRAM IN AN OPEN POPULATION

Edgar Rodríguez-, Fuentes, Fátima Higuera-De La Tijera, María Luisa Hernández-Medel, José Luis Pérez-Hernández, Raúl Serrano-Loyola, Guadalupe Guerrero-Avendaño

Ann Hepatol. 2023;28 Supl 1:100904.58

Full text access

P-65 NOREPINEPHRINE INFUSION AS AN ALTERNATIVE TO ALBUMIN POST LARGE VOLUMEN PARACENTESIS IN CIRRHOTIC PATIENTS

Ernaldo Morales-Mairena, Fátima Higuera-De La Tijera, Andrea Enríquez-Constantino, Daniel Santana Vargas, José LuisPérez-Hernández

Ann Hepatol. 2023;28 Supl 1:100904.59

Full text access

P-66 CARDIOVASCULAR RISK PROFILE AND ATHEROSCLEROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

Maria Eduarda de Almeida Oliveira, Sérgio Augusto Antônio, Davi Cassiano Costa, Raphael Carreiro Moura, Daniele Araújo de Azeredo Coutinho, Carlos Roberto de Andrade Junior, Maria Auxiliadora Saad, Priscila Pollo Flores, Débora Vieira Soares

Ann Hepatol. 2023;28 Supl 1:100904.60

Full text access

P-67 USEFULNESS OF 3 DIFFERENT POINTS OF THE LIVER TO EVALUATE FIBROSIS BY TRANSITIONAL ELASTOGRAPHY

Ernaldo Morales Mairena, Fátima Higuera-de-la Tijera, Daniel Santana Vargas, Erika Bojorges Valdez, Andrés Burak Leipuner, J García Espinosa, Felix García Juárez, José Luis Pérez-Hernández

Ann Hepatol. 2023;28 Supl 1:100904.61

Full text access

P- 69 CHRONIC HEPATITIS B: EPIDEMIOLOGICAL CHARACTERISTICS, EVOLUTION AND PREVALENT PHASES, IN REFERENCE CENTERS IN PARAGUAY

Mirian Colarte, Marcos Girala, Lorena Martinez, Sebastian Diaz, Jesús Ortiz

Ann Hepatol. 2023;28 Supl 1:100904.62

Full text access

P-70 HEPATITIS B IMMUNITY AMONG CHRONIC RENAL DISEASE UNDER HEMODIALYSIS

Alanna Calheiros Santos, Juliana Gil Melgaço, Lucas Lima da Silva, Vanessa Duarte da Costa, Juliana Custódio Miguel, Elisangela Ferreira da Silva, Julia Trece Marques, Giselle Prado do Nascimento, ... Livia Melo Villar

Ann Hepatol. 2023;28 Supl 1:100904.63

Full text access

P- 71 BACTERIAL INFECTIONS IN CIRRHOTIC PATIENTS: ARE WE FACING AN EPIDEMIOLOGICAL CHANGE?

Bulaty Sofía, Jaureguizahar Fernanda, Zitelli Ludmila, Tamagnone Norberto, Navas Lisandro, Rifrani Gabriel, Ahumada Natalia, Cortese María Mercedes, ... Bessone Fernando

Ann Hepatol. 2023;28 Supl 1:100904.64

Full text access

P- 73 ULTRASOUND VISUALIZATION OF THE LIVER

Ezequiel Demirdjian, Diego Arufe, Mariana Moreyra, Guillermo Troiani, Analia Cellerino, Diego Costa, Maria Pia Raffa

Ann Hepatol. 2023;28 Supl 1:100904.65

Full text access

P- 75 COMPARISON OF EUS-GUIDED COIL PLUS CYANOACRYLATE VS CONVENTIONAL CYANOACRYLATE TECHNIQUE IN THE MANAGEMENT OF ACUTE GASTRIC VARICEAL BLEEDING. WHICH ONE IS BETTER?

Aldo Carvajal, Jorge Vargas, Ana Madrigal, Carolina Gutierrez, Manfred Aguilar, Marlon Rojas, Luis Arguedas, Pablo Cortes, ... Francisco Hevia

Ann Hepatol. 2023;28 Supl 1:100904.66

Full text access

P- 76 ELEVATED FIBROSIS LEVEL IN PATIENTS COINFECTED WITH HEPATITIS AND COVID-19 DURING A LONGITUDINAL STUDY

Lucas Lima Da Silva, Vanessa Duarte Da Costa, Alanna Calheiros Santos, Juliana Custódio Miguel, Luciana Texeira De Barros E Vasconcellos, Wilian Jeans Wiggers, Claudia Alexandra Pontes Ivantes, Priscila Pollo-Flores, ... Livia Melo Villar

Ann Hepatol. 2023;28 Supl 1:100904.67

Full text access

P- 77 EPIGENOME OF PATIENTS WITH LIVER FIBROSIS, WITH SUSTAINED VIRAL RESPONSE TO HCV IN LIVER BIOPSY AND LIQUID BIOPSY REVEALS THE ASSOCIATION OF DNA METHYLATION AND miRNA EXPRESSION WITH THE DEGREE OF SEVERITY

Ricardo De la Rosa-Bibiano, Rebeca Escutia-Gutiérrez, Eira Cerda-Reyes, Juan Manuel Aguilar, Ana Soledad Sandoval-Rodríguez, Juan Armendáriz-Borunda

Ann Hepatol. 2023;28 Supl 1:100904.68

Full text access

P- 78 DIETHYlNITROSAMINE AND 2-ACETYLAMINOFLUORENE CHRONIC ADMINISTRATION LEADS TO BIOCHEMICAL, HISTOLOGIC AND GENETIC CHANGES RELATED TO HEPATOCELLULAR CARCINOMA IN WISTAR RATS

Jaime Sánchez-Meza, Marina Campos-Valdez, José Alfredo Domínguez-Rosales, Saraí Citlalic Rodríguez-Reyes, Erika Martínez-López, Juliana Marisol Godínez-Rubí, Adriana María Salazar-Montes, Laura Verónica Sánchez-Orozco

Ann Hepatol. 2023;28 Supl 1:100904.69

Full text access

P- 79 LIVER TRANSPLANTATION FOR HEPATOCELLULAR, LOOKING FOR THE BETTER SELECTION CRITERIA. RESULTS FROM THE URUGUAYAN LIVER TRANSPLANT PROGRAM

Cinthya Coronado, Josemaría Menéndez, Alejo Gestal, Victoria Mainardi, Solange Gerona

Ann Hepatol. 2023;28 Supl 1:100904.70

Full text access

P- 80 DIFFERENTIAL EXPRESSION OF MATRIX METALLOPROTEINASE 7 IN CHRONIC LIVER DISEASES

Daniel Montes de Oca-Angeles, M. Lemus-Peña, A. Hernandez-Barragan, M. Hernández-Santillán, Moisés Martinez-Castillo, Z. Medina-Avila, D. Santana-Vargas, A. Torre-Delgadillo, ... G. Gutiérrez-Reyes

Ann Hepatol. 2023;28 Supl 1:100904.71

Full text access

P- 81 PREVALENCE OF HEV INFECTION IN HIV CARRIERS, PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND CIRRHOTIC PATIENTS

Luan Henrique Paim Santos, Luíza Araújo de Santana Cavalcanti, Daniela Santana Mendes, Victoria Cruz Paraná, Júlia Stifelman Freire Alves, Fernanda Souza Novais, Sidelcina Rugieri Pacheco, Maria Alice Sant'Anna Zarife, ... Luciano Kalabric Silva

Ann Hepatol. 2023;28 Supl 1:100904.72

Full text access

P- 82 VERY HIGH PREVALENCE OF STEATOSIS AND STRIKINGLY ELEVATED ANTIE VIRUS ANTIBODIES: RESULTS OF A LIVER DISEASE SCREENING CAMPAIGN

Alceo Galimberti, Victoria Trevizan, Sofia Bulaty, Fernanda Jaureguizahar, Antonela Ferrari, Ludmila Zitelli, Norberto Tamagnone, Juan Maurino, ... Fernando Bessone

Ann Hepatol. 2023;28 Supl 1:100904.73

Full text access

P- 84 ENDOSCOPIC ULTRASOUND GUIDED LIVER BIOPSY, IS IT READY FOR PRIMETIME?

Daniela Hernández-Castro, Wagner Ramírez-Quesada, Carolina Gutiérrez-Ramírez, Sylvia Álvarez-Umaña, José Pablo Cortes-Navarrete, Aldo Carvajal-González, Francisco Hevia-Urrutia, Ana Lorena Madrigal-Méndez, Jorge Vargas-Madrigal

Ann Hepatol. 2023;28 Supl 1:100904.74

Full text access

P- 85 HIGHER LEVELS OF ALKALINE PHOSPHATASIS AFTER 6-MONTH TREATMENT WITH URSODEOXYCHOLIC ACID WERE ASSOCIATED WITH EVOLUTION TO ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE

Diogo Delgado Dotta, Marcus Vinicius De Acevedo Garcia Gomes, Ana Elisa Rabe Caon, Davi Viana Ramos, Luisa Leite Barros, Débora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado

Ann Hepatol. 2023;28 Supl 1:100904.75

Full text access

P- 89 CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH LIVER CIRRHOSIS AT A REFERRAL CENTER IN PARAGUAY

Elías Morán, Marcos Girala, Guillermo Fernández, Adriana Medina, Jesús Ortiz Villalba

Ann Hepatol. 2023;28 Supl 1:100904.76

Full text access

P- 90 EFFECT OF THE DELIVERY OF WRITTEN INFORMATION ON DISEASE-RELATED KNOWLEDGE IN PATIENTS WITH CIRRHOSIS AND ASSOCIATED FACTORS

Daniela Simian, Rosario Pino, Camila Vera, Emerson Rioseco, Camila Campos, Axel Polanco, Máximo Cattaneo, Juan Pablo Roblero, ... Jaime Poniachik

Ann Hepatol. 2023;28 Supl 1:100904.77

Full text access

P- 91 CHANGES IN EARLY VISUAL PERCEPTION IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY

José Luis Pérez Hernández, Diana Montemira Orozco, Christian Israel Hinojosa-Segura, Julieta Zavala Ramírez, Imran Gibran Cruz Reyes, Maria Escobedo Silva, Fatima Higuera-de la Tijera, Daniel Santana Vargas

Ann Hepatol. 2023;28 Supl 1:100904.78

Full text access

P- 93 INTERVENTIONS AND CLINICAL OUTCOMES IN PATIENTS EXCLUDED FROM PRE-LIVER TRANSPLANT EVALUATION IN A SINGLE CENTER EXPERIENCE

Alejandra Amaya, Margarita Gutiérrez, Martín Garzón, Fabiola Villalba, Yanet Mendez, Oscar Beltran, Geovanny Hernández, Carolina Salinas, ... Varón Adriana

Ann Hepatol. 2023;28 Supl 1:100904.79

Full text access

P- 97 CHARACTERIZATION OF PATIENTS INFECTED WITH HEPATITIS C IN 2 REFERENCE CENTERS IN PARAGUAY, FROM APRIL 2000 TO SEPTEMBER 2021

José Mongelos, Marcos Girala, Sebastian Diaz, Sara Melgarejo, Jesus Ortiz

Ann Hepatol. 2023;28 Supl 1:100904.80

Full text access

P- 99 ASSOCIATION OF LIVER ABNORMALITIES WITH DISEASE SEVERITY IN COVID-19

Jhankarla Hinojosa, Caio Magrini, Perla Schulz, Andrea Vieira, Roberto da Silva Junior

Ann Hepatol. 2023;28 Supl 1:100904.81

Full text access

P- 101 TREATMENT OF PATIENTS INFECTED WITH HEPATITIS C VIRUS IN TWO REFERENCE CENTERS IN PARAGUAY.

José Mongelós, Marcos Girala, Mariam Garayo, Sara Melgarejo, Sergio Morinigo, Jesús Ortiz Villalba

Ann Hepatol. 2023;28 Supl 1:100904.82

Full text access

P- 102 CLINICAL CHARACTERISTICS OF LIVER CIRRHOSIS SECONDARY TO METABOLIC SYNDROME AND COMPARISON WITH ETHYL CIRRHOSIS

Laura Martínez, Elias Morán, Marcos Girala

Ann Hepatol. 2023;28 Supl 1:100904.83

Full text access

P- 103 PREVALENCE OF SARCOPENIA IN CIRRHOTIC PATIENTS IN AN OUTPATIENT SERVICE IN BRAZIL

Carolina Pretti Tumang de Andrade, Lara Ferrari Dalcumune, Nubia Mesquita Fiorese, Livia Zardo Trindade, Felipe Bertollo Ferreira, Mariana Poltronieri Pacheco

Ann Hepatol. 2023;28 Supl 1:100904.84

Full text access

P- 104 EXPERIENCE AND CARDIOVASCULAR OUTCOMES IN POST-LIVER TRANSPLANT PATIENTS AT A REFERENCE TRANSPLANT CENTER IN COLOMBIA

Carlos Martinez, Catalina Gutierrez, Daniel Rojas, Sandra Saummet, Camila Galindo, Rafael Conde, Adriana Varon

Ann Hepatol. 2023;28 Supl 1:100904.85

Full text access

P- 105 DETECTION OF HEPATITIS D VIRUS IN PATIENTS WITH CHRONIC HEPATITIS B FROM SOUTH AMERICA.

María Belén Pisano, Viviana E. Ré, Enrique Carrera, Domingo Balderramo, Jhon Prieto, Javier Díaz-Ferrer, Marco Arrese, Angelo Z. Mattos, ... Andre Boonstra

Ann Hepatol. 2023;28 Supl 1:100904.86

Full text access

P- 107 EPIDEMIOLOGY, CLINICAL AND TISSUE CHARACTERISTICS OF A LARGE COHORT OF NAFLD/NASH FROM SOUTH AMERICA

Jhon Prieto Ortiz, Joseph Akambase, Angelo Mattos, Enrique Carrera Estupinan, Javier Diaz Ferrer, Andre Curia, Patricia Gallardo, Esteban Gonzalez Ballerga, ... Jose Debes

Ann Hepatol. 2023;28 Supl 1:100904.87

Full text access

P- 108 POLYMORPHISMS OF HLA (LOCI DR 4*) IN HISPANICS AS RISK FACTOR FOR DE-NOVO AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION

Adriana Varón, Luisa Santos, Oscar Beltrán, Martin Garzón, Geovanny Hernandez, Carolina Salinas, Maria C. Torres, Andres Murcia, ... Gilberto Mejia

Ann Hepatol. 2023;28 Supl 1:100904.88

Full text access

P- 109 NON-INVASIVE ASSESSMENT OF FIBROSIS REGRESSION IN VIROLOGICAL RESPONDERS SUSTAINED BY HEPATITIS C VIRUS

Dania Anaberta Campos García, Sánchez Abel

Ann Hepatol. 2023;28 Supl 1:100904.89

Full text access

P-110 BIOPSY IN FOCAL LIVER LESIONS: CORRELATION FROM CLINICAL TO HISTOPATHOLOGY

Enrique Carrera, Freddy Holguin, Gabriela Quingalombo, Estibalys Zambrano, Silvia Lozada

Ann Hepatol. 2023;28 Supl 1:100904.90

Full text access

P- 111 MORTALITY ON LIVER TRANSPLANT WAITING LIST: ANALYSIS OF A TRANSPLANT CENTER IN COLOMBIA

Cristina Torres, Andres Murcia, Diana Benavides, Oscar Beltran, Martin Garzon, Carolina Salinas, Geovanny Hernandez, Gilberto Mejia, ... Adriana Varon

Ann Hepatol. 2023;28 Supl 1:100904.91

Full text access

P- 112 METABOLIC FATTY LIVER DISEASE: FIBROSIS AND SARCOPENIA FREQUENCIES AND CORRELATION

Helen Cristine Saldanha Ferreira, Hévila de Farias Passos, Rafaela Cunha da Silva, Larissa Carvalho Pereira, Juliana Pereira da Silveira dos Santos, Patrick Machado Cibin, Vinicius Costa Viana, Gabriela Landier, ... Priscila Pollo Flores

Ann Hepatol. 2023;28 Supl 1:100904.92

Full text access

P- 113 TREATMENT OF CHRONIC HEPATITIS B IN TWO REFERENCE CENTERS IN PARAGUAY.

Mirian Colarte, Marcos Girala, Lorena Martínez, Sebastián Diaz, Jesús Ortiz

Ann Hepatol. 2023;28 Supl 1:100904.93

Full text access

P-114 APPLICATION OF THE DONOR RISK INDEX IN LIVER TRANSPLANTATION IN THE MAIN TRANSPLANT CENTER IN PERU

P.Martin Padilla-Machaca, Omar Mantilla, José Rivera, Alfonso Solar, Bertha Cárdenas, Carmen Cerrón, Saul Espinoza, Wilmer Bacilio, ... Carlos Rondón

Ann Hepatol. 2023;28 Supl 1:100904.94

Full text access

P-115 SUSCEPTIBILITY TO LIVER DAMAGE IN WOMEN DUE TO RISKY ALCOHOL CONSUMPTION.

José Luis Pérez-Hernández, Ernaldo Morales-Mairena, Andrea Enríquez-Constantino, Daniel Angel Santana Vargas, Fátima Higuera-de la Tijera

Ann Hepatol. 2023;28 Supl 1:100904.95

Full text access

P-116 AUTOIMMUNE DISEASES ASSOCIATED WITH AUTOIMMUNE HEPATITIS: EXPERIENCE IN TWO PARAGUAYAN CENTERS.

Florencia Otazú, Marcos Girala, Pedro Mercado, Guillermo Fernández, Jesús Ortiz Villalba

Ann Hepatol. 2023;28 Supl 1:100904.96

Full text access

P-117 HEPATOBILIARY INJURIES: EXPERIENCE OF THE MULTIDISCIPLINARY COMMITTEE AT THE HOSPITAL DE ESPECIALIDADES EUGENIO ESPEJO (HEE) IN QUITO – ECUADOR

Estibalys Zambrano, Silvia Lozada, Freddy Holguín, Gabriela Quingalombo, Enrique Carrera

Ann Hepatol. 2023;28 Supl 1:100904.97

Full text access

P-118 HEPATOCELLULAR CARCINOMA. AN EXPERIENCE IN A TRANSPLANT CENTER IN COLOMBIA

Adriana Varón, José Leonardo Pérez, Cristina Torres, Juan Manuel Pérez, José Gabriel Caviedes, Diego Piñeros, Gilberto Mejía, Jairo Rivera, ... Oscar Beltrán

Ann Hepatol. 2023;28 Supl 1:100904.98

Full text access

P-119 LIVER TRANSPLANTATION IN ACUTE ON CHRONIC LIVER FAILURE (ACLF): RESULTS OF THE MAIN TRANSPLANT CENTER OF PERU

Carmen Ana Cerron Cabezas, Rosa Luz Lopez Martinez, Gino Salcedo Bermudez, Pedro Martin Padilla Machaca, Bertha Eliana Cardenas Ramirez, Wilmer Bacilio Calderon, Omar Mantilla Cruzatti, Jose Rivera Romani, ... Carlos Felix Rondon Leyva

Ann Hepatol. 2023;28 Supl 1:100904.99

Full text access

P-120 ANTHROPOMETRIC AND METABOLIC PROFILE IN NON-ALCOHOLIC FATTY LIVER DISEASE

Lara Ramos de Prado, Mariana Sophia Santos Almeida, Ana Ester Amorim de Paula, Maria Auxiliadora Nogueira Saad, Rosa Leonora Salerno Soares, Priscila Pollo Flores, Débora Vieira Soares

Ann Hepatol. 2023;28 Supl 1:100904.100

Full text access

P-121 CORRELATION BETWEEN HEPATOPULMONARY SYNDROME AND OXYGEN SATURATION PULSE OXIMETRY IN CIRRHOTIC PATIENTS

Dayana Christo, Verônica Nicoli, Perla Schulz, Andrea Vieira, Roberto da Silva Junior

Ann Hepatol. 2023;28 Supl 1:100904.101

Full text access

P-122 MAFLD PREVALENCE AND FACTORS ASSOCIATED WITH LIVER STEATOSIS IN PATIENTS WITH TRAUMATIC SPINAL CORD INJURY

Fernanda Barros Viana Coelho, Luiz Carlos Cassemiro, Sandro Barbosa De Oliveira, José Tadeu Stefano, Claudia Pinto Marques Souza De Oliveira

Ann Hepatol. 2023;28 Supl 1:100904.102

Full text access

P-123 HEPATOCELLULAR CARCINOMA SURVIVAL: EXPERIENCE OF THE MULTIDISCIPLINARY COMMITTEE AT HOSPITAL ESPECIALIDADES EUGENIO ESPEJO IN QUITO – ECUADOR

Enrique Carrera, Jaysoom Abarca, German Abbdo, Cintya Borja, Wendy Calderon, Gabriela Camacho, Ximena Cuenca, Freddy Holguin, ... Estibalys Zambrano

Ann Hepatol. 2023;28 Supl 1:100904.103

Full text access

P-124 TITLE: CLINICAL CHARACTERISTICS OF CIRRHOTIC PATIENTS WITH VARICEAL BLEEDING IN A SINGLE CENTER EXPERIENCE. DESCRIPTIVE STUDY

Martin Garzon, Maria Lucia Bernal, David Ramirez, Geovanny Hernandez, Carolina Salinas, Jorge Ceballos, Enrique Ponce, Cristina Torres, ... Oscar Beltran

Ann Hepatol. 2023;28 Supl 1:100904.104

Full text access

P-126 PREVALENCE OF LIVER FIBROSIS IN THE INFECTION BY THE HEPATITIS B AND C VIRUS IN GUATEMALA

Abel Sanchez, Katherine Maldonado, Johana Samayoa

Ann Hepatol. 2023;28 Supl 1:100904.105

Full text access

P-129 LIVER TRANSPLANTATION IN PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA. EXPERIENCE OF TWO CASES AT AN ARGENTINE HHT REFERRAL CENTER

Marcelo Serra, Juan Manuel Diaz, Anibal Arias, Martín De Santibañes, Eduardo De Santibañes, Juan Carlos Bandi

Ann Hepatol. 2023;28 Supl 1:100904.106

Full text access

P-130 CONGENITAL PORTOSYSTEMIC SHUNTS: EXPERIENCE IN A THIRD LEVEL CHILDREN`S HOSPITAL

Micaela Wisniacki, Carol Lezama Elecharri, Marcela Galoppo, Maria Solaegui, Alejandra Pedreira, Sabrina Torres, Eduardo Galli, Guillermo Eiselle, ... Elena De Mateo

Ann Hepatol. 2023;28 Supl 1:100904.107

Full text access

O-1 ECONOMIC IMPACT OF LONG-TERM ALBUMIN INFUSIONS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS AND UNCOMPLICATED ASCITES FROM THE BRAZILIAN PUBLIC AND PRIVATE HEALTHCARE SYSTEMS PERSPECTIVES

Carlos Terra, Elisabet Viayna, Laura Ayzin, Cristina Fuster, Susana Aceituno, Maria Soler, Claudio Tafla

Ann Hepatol. 2023;28 Supl 1:100904.108

Full text access

O-2 CHARACTERIZATION OF SERUM LEVELS OF BILE ACIDS, EXTRACELLULAR VESICLES AND ITS CARGO IN ALCOHOL-ASSOCIATED LIVER DISEASE

Jorge Arnold, Luis Antonio Díaz, Francisco Idalsoaga, María Ayala Valverde, Gustavo Ayares, Paula Rivera, Nancy Solís, Fidel Allende, ... Juan Pablo Arab

Ann Hepatol. 2023;28 Supl 1:100904.109

Full text access

O-4 CLINICAL, HISTOLOGICAL AND SEROLOGICAL FEATURES OF AUTOIMMUNE-LIKE ACUTE LIVER INJURY AFTER SARS-COV-2 VACCINATION

Marlene Padilla Lopez, Natalia Sobenko, Lucrecia Garcia Olivera, Agustina Martinez Garmendia, Eduardo Mullen, Paola Casciato, Sebastian Marciano, Alejandra Villamil

Ann Hepatol. 2023;28 Supl 1:100904.110

Full text access

O-5 INTEGRATED ANALYSIS OF ARCHAEAL, FUNGAL AND PROTOZOAN GUT TRANSCRIPTOME IN METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN ARGENTINA

Bárbara Suárez, María Florencia Mascardi, Flavia Noelia Mazzini, M. Ruda Vera, Sebastián Marciano, Paola Casciato, Adrián Narvaez, Leila Haddad, ... Julieta Trinks

Ann Hepatol. 2023;28 Supl 1:100904.111

Full text access

O-6 ENHANCED METABOLISM OF AROMATIC AMINO ACIDS AND LOW-DIVERSITY GUT MICROBIOTA: SIGNATURES OF HEPATIC ENCEPHALOPATHY IN DECOMPENSATED CIRRHOTIC PATIENTS FROM WESTERN MEXICO

Tonatiuh Abimael Baltazar-Díaz, Luz Alicia González-Hernández, Juan Manuel Aldana-Ledesma, Donovan Cortina-Romero, Marcela Peña-Rodríguez, Alejandra Natali Vega-Magaña, Sara Minia Zepeda-Morales, Rocío Ivette López-Roa, ... Miriam Bueno-Topete

Ann Hepatol. 2023;28 Supl 1:100904.112

Full text access

O-7 LIVER TOXICITY OF TYROSINE KINASE INHIBITORS: A DESCRIPTIVE ANALYSIS FROM SLATINDILI NETWORK

Nelia Hernández, Fernando Bessone, Daniela Chiodi, Norberto Tamagnone, Inmaculada Medina-Caliz, María Isabel Lucena, Raúl Andrade

Ann Hepatol. 2023;28 Supl 1:100904.113

Full text access

O-8 CHARACTERIZATION AND EPIDEMIOLOGICAL CHANGES OF PATIENTS WITH HEPATITIS C VIRUS TREATED IN THE CHILEAN PUBLIC HEALTH SYSTEM FROM 2016 TO 2021.

Luis Salazar, Carlos Valdebenito, Alejandro Carvajal, Gonzalo Veloso, Herman Aguirre, Gabriel Mezzano

Ann Hepatol. 2023;28 Supl 1:100904.114

Full text access

O-9 THE CHANGING EPIDEMIOLOGY OF HEPATOCELLULAR CARCINOMA IN SOUTH AMERICA: A REPORT FROM THE SOUTH AMERICAN LIVER RESEARCH NETWORK

Enrique Carrera Estupinan, Angelo Mattos, Javier Diaz Ferrer, Marina Farah, Domingo Balderramo, Estefania Liza Vaca, Marco Arrese Jimenez, Jhon Prieto Ortiz, Jose Debes

Ann Hepatol. 2023;28 Supl 1:100904.115

Full text access

Federico Piñero, Charlotte Costentin, Helena Degroote, Quirino Lai, Fernando Rubinstein, Christophe Duvoux

Ann Hepatol. 2023;28 Supl 1:100904.116

Full text access

O-11 THE PUBLIC HEALTH POLICIES REDUCE THE LONG-TERM BURDEN OF ALCOHOL-ASSOCIATED LIVER DISEASE WORLDWIDE: DEVELOPMENT OF A PREPAREDNESS INDEX

Luis Antonio Díaz, Eduardo Fuentes-López, Francisco Idalsoaga, Jorge Arnold, Gustavo Ayares, Macarena Cannistra, Danae Vio, Andrea Márquez-Lomas, ... Juan Pablo Arab

Ann Hepatol. 2023;28 Supl 1:100904.117

Full text access

O-12 CHARACTERIZATION AND UTILIZATION OF HCV-POSITIVE DONORS IN ARGENTINA

Manuel Mendizabal, Margarita Anders, Ariel Antik, Federico Piñero, Gabriela Hidalgo, Daniela Hansen Krogh, Viviana Tagliafichi, Marcelo Silva, Liliana Bisigniano

Ann Hepatol. 2023;28 Supl 1:100904.118

Full text access

O-13 PERFORMANCE OF PRE-TRANSPLANT CRITERIA IN PREDICTION OF HEPATOCELLULAR CARCINOMA PROGRESSION AND WAITLIST DROPOUT

Federico Piñero, Marcos Thompson, Ilka Boin, Aline Chagas, Emilio Quiñonez, Carla Bermúdez, Mario Vilatobá, Luisa Santos, ... Marcelo Silva

Ann Hepatol. 2023;28 Supl 1:100904.119

Full text access

O-14 NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CORONARY HEART DISEASE

Máximo Cattaneo, Juan Pablo Roblero, Luis Vega, Marcelo Salinas, Andrea Urra, Daniela Simian, Rosario Pino, Álvaro Urzúa, ... Jaime Poniachik

Ann Hepatol. 2023;28 Supl 1:100904.120

Full text access

O-15 INFECTIONS BY MULTI-DRUG RESISTANT BACTERIA WERE INDEPENDENTLY ASSOCIATED WITH HOSPITAL MORTALITY IN CIRRHOTICS WITH ACUTE DECOMPENSATION: A PROSPECTIVE STUDY ON 433 ADMISSIONS

Gabriela Ruffillo, Juan Cruz Codd, Limbert Jesús Padilla Martínez, Miguel Angel Puga Tejada, Adriana Fernández Lausi, Graciela Landeira, Graciela Priore, Cristina Longo, ... Eduardo Fassio

Ann Hepatol. 2023;28 Supl 1:100904.121

Full text access

O-16 MELD-NA AND MELD3.0 HAVE THE BEST PERFORMANCE TO PREDICT THE 28-DAY RISK OF DEATH IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS IN THE MEXICAN POPULATION

Fátima Higuera-De La Tijera, Claudia Dorantes-Nava, Alfredo Servín-Caamaño, Francisco Salas-Gordillo, Juan Miguel Abdo-Francis, Gabriela Gutiérrez-Reyes, P Diego-Salazar, MY Carmona-Castillo, ... José Luis Pérez-Hernández

Ann Hepatol. 2023;28 Supl 1:100904.122

Full text access

O-17 STUDY OF THE ASSOCIATION BETWEEN SERUM LEVELS OF SYSTEMIC INFLAMMATORY MARKERS AND ADVANCED FIBROSIS STAGE IN INFECTED PATIENTS WITH HEPATITIS DELTA VIRUS GENOTYPE 3

Mauricio Campos, Juan Miguel Salcedo, Deusilene Vieira, Songeli Freire, Raymundo Paraná, María Isabel Schinoni

Ann Hepatol. 2023;28 Supl 1:100904.123

Full text access

O-18 ETHNIC DISPARITIES IN HISPANIC POPULATION WITH ALCOHOL ASSOCIATED LIVER DISEASE AND TRANSPLANT ENLISTED PATIENTS: A RETROSPECTIVE STUDY OF TWO LARGE DATABASES IN THE UNITED STATES FROM 2011-2018

Gustavo Ayares, Luis Antonio Díaz, Eduardo Fuentes-López, Francisco Idalsoaga, Jorge Arnold, Thomas Cotter, Winston Dunn, Douglas Simonetto, ... Juan Pablo Arab

Ann Hepatol. 2023;28 Supl 1:100904.124

Full text access

O-19 COLLABORATIVE CARE TOWARDS MICROELIMINATION OF HEPATITIS C VIRUS IN A DIALYSIS POPULATION IN SOUTHERN BRAZIL

Hugo Cheinquer, Alexandre de Araujo, Dirceu da Silva Reis

Ann Hepatol. 2023;28 Supl 1:100904.125

Full text access

O-20 MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF HEPATITIS B VIRUS SUBGENOTYPE F1b CLUSTERS: UNRAVELING ITS ROLE IN HEPATOCARCINOGENESIS

María Mercedes Elizalde, Laura Mojseijczuk, Micaela Speroni, Luciana Tadey, Belén Bouzas, Lilia Mammana, Rodolfo Héctor Campos, Diego Martín Flichman

Ann Hepatol. 2023;28 Supl 1:100904.126

Full text access

O-21 EVIDENCE OF SUBOPTIMAL PUBLIC HEALTH POLICIES ON HEPATOCELLULAR CARCINOMA IN THE AMERICAS: A HUGE DEBT OF OUR REGION

Luis Antonio Díaz, Gustavo Ayares, Francisco Idalsoaga, Jorge Arnold, Blanca Norero, Oscar Corsi, Gonzalo Pizarro, Sergio García, ... Juan Pablo Arab

Ann Hepatol. 2023;28 Supl 1:100904.127

Full text access

O-22 DIFFERENTIAL MUTATION PATTERN ASSOCIATED WITH HEPATITIS B E ANTIGEN SEROCONVERSION BETWEEN SUBGENOTYPE F1b CLUSTERS: POTENTIAL ROLE IN PATHOGENESIS

Micaela Martínez, Mercedes Elizalde, Micaela Speroni, Rodolfo Campos, Diego Flichman

Ann Hepatol. 2023;28 Supl 1:100904.128

Full text access

O-23 HEPATITIS B VIRUS STATUS OF ORGAN DONORS IN ARGENTINA

Maria Anders, Ariel Antik, Manuel Mendizabal, Federico Piñero, Daniela Hansen Krogh, Federico Orozco, Viviana Tagliafichi, Julia Brutti, ... Liliana Bisignano

Ann Hepatol. 2023;28 Supl 1:100904.129

Full text access

O-24 PIRFENIDONE PREVENTS NEOPLASTIC LESIONS DEVELOPMENT BY OXIDATIVE, FIBROGENIC, ANTIPROLIFERATIVE AND EPIGENETIC MECHANISMS REGULATION IN A MODEL OF CHEMICAL HEPATOCARCINOGENESIS

Hipólito Otoniel Miranda-Roblero, Hugo Christian Monroy-Ramírez, Marina Galicia-Moreno, Ana Sandoval-Rodriguez, Arturo Santos, Juan Armendáriz-Borunda

Ann Hepatol. 2023;28 Supl 1:100904.130

Full text access

O-25 ASSESSMENT OF MODELS FOR PREDICTING RESPONSE TO CORTICOIDS TREATMENT IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL COHORT STUDY

Francisco Idalsoaga, Luis Antonio Díaz, Gustavo Ayares, Jorge Arnold, Winston Dunn, Yanming Li, Ashwani Singal, Doug Simonetto, ... Juan Pablo Arab

Ann Hepatol. 2023;28 Supl 1:100904.131

Full text access

O-26 IMMUNE PROFILING PROVIDES A SET OF 5 CYTOKINES TO DETECT HEPATOCELLULAR CARCINOMA RELATED TO VIRAL HEPATITIS IN SOUTH AMERICAN PATIENTS

Jose Debes, Enrique Carrera Estupinan, Melina Rocio Ferreiro, Angelo Mattos, Domingo Balderramo, Maria Massotti, Joe Koopmeiners, Andre Boonstra

Ann Hepatol. 2023;28 Supl 1:100904.132

Full text access

O-30 ALCOHOL-HARM PARADOX IN LATIN AMERICA: HOW TO STUDY IT DESPITE DATA LIMITATIONS? THE CHILEAN EXPERIENCE

Juan Pablo Roblero, Juan Pablo Arab, Jaime Poniachik, Ramon Bataller, Luis Antonio Díaz

Ann Hepatol. 2023;28 Supl 1:100904.133

Full text access

O-31 DIAGNOSTIC PERFORMANCE OF BAVENO VII CRITERIA FOR EXCLUSION OF ESOPHAGEAL VARICES: A RETROSPECTIVE STUDY

Williams Celedonio Campos, Celide Campoverde-Cueva, Brayan Campos, Rommel Zambrano-Huailla, Alejandra Zevallos, Jorge Garavito-Renteria

Ann Hepatol. 2023;28 Supl 1:100904.134

Full text access

O-32 FULMINANT AUTOIMMUNE HEPATITIS: CLINICAL PRESENTATION, OUTCOME AND PROGNOSTIC FACTORS.

Alejandra Villamil, Marlene Padilla, Eduardo Mullen, Juan Carlos Bandi, Gabriel Carballo, Natalia Sobenko, Sebastian Marciano

Ann Hepatol. 2023;28 Supl 1:100904.135

Full text access

O-33 PREVALENCE OF HIGH-RISK NON-ALCOHOLIC STEATOHEPATITIS ACCORDING TO THE FAST® INDEX IN A GROUP OF DIABETIC PATIENTS

Andrés Burak-Leipuner, Fatima Higuera-de la Tijera, Alfredo Servín-Caamaño, Javier Romero-Bermúdez, Laura Ceceña-Martínez, Felix García-Gorrosquieta, Kevin Vázquez-Hernández, Nidia Uribe-Rivera, ... José Luis Pérez-Hernández

Ann Hepatol. 2023;28 Supl 1:100904.136

Full text access

O-34 PATIENT AND GRAFT SURVIVAL IN RECIPIENTS OF DE NOVO SIMULTANEOUS LIVER-KIDNEY TRANSPLANTATION

Agustina Martínez Garmendia, Marlene Padilla, Tomas Fescina, María Cora Giordani, Gustavo Greloni, Rosana Groppa, Nora Imperialii, Paola Casciato, Sebastián Marciano

Ann Hepatol. 2023;28 Supl 1:100904.137

Full text access

O-35 EPIDEMIOLOGY, CLINICAL AND TISSUE CHARACTERISTICS OF A LARGE COHORT OF NAFLD/NASH FROM SOUTH AMERICA

Jhon Prieto Ortiz, Joseph Akambase, Angelo Mattos, Enrique Carrera Estupinan, Javier Diaz Ferrer, Andre Curia, Patricia Gallardo, Esteban Gonzalez Ballerga, ... Jose Debes

Ann Hepatol. 2023;28 Supl 1:100904.138

Full text access

O-36 UTILITY OF DRIED BLOOD SAMPLES FOR HEPATITIS C VIRUS GENOTYPING AMONG HCV/HIV-COINFECTED INDIVIDUALS

Geane Lopes Flores, Barbara Vieira Do Lago, Amanda Rodrigues Caetano, Vanessa Alves Marques, Daniela Rodrigues Pontes Pires, Carlos Eduardo Brandão-Mello, Cristiane Villela-Nogueira, Lia-Laura Lewis Ximenes, AndLivia Melo Villar

Ann Hepatol. 2023;28 Supl 1:100904.139

Full text access

O-37 AMOXICILLIN-CLAVULANATE INDUCED LIVER INJURY: TEN YEARS EXPERIENCE FROM LATINDILI REGISTRY.

Nelia Hernandez, Fernando Bessone, Daniela Chiodi, Manuel Mendizabal, A Sanchez, Ezequiel Ridruejo, Carla Bianchi, Carmen Pollio, ... María Isabel Lucena

Ann Hepatol. 2023;28 Supl 1:100904.140

Full text access

O-38 FULMINANT WILSON: A WELL-DEFINED ENTITY. HOW TO DIAGNOSE IT QUICKLY TO PREVENT MORTALITY

Francisco Hevia, Mónica Penón, Stephanie Lotz, Alfredo Mora, Gabriela Jiménez, Ramsés Badilla, Mildred Jiménez, Manuel Saborío, ... Danny Alvarado

Ann Hepatol. 2023;28 Supl 1:100904.141

Full text access

O-39 CLINICAL CHARACTERISTICS AND OUTCOME OF DRUG-INDUCED LIVER INJURY DUE TO ANTINEOPLASTIC AND BIOLOGICAL AGENTS

Fernando Bessone, Nelia Hernandez, Raymundo Parana, Maria Isabel Schinoni, Manuel Mendizabal, Adriana Sanchez, Vinicius Nunes, Ezequiel Ridruejo, ... Raul J Andrade

Ann Hepatol. 2023;28 Supl 1:100904.142

Full text access

O-40 PROGNOSTIC ROLE OF MAGNETIC RESONANCE OF THE ABDOMEN WITH INTRAVENOUS CONTRAST AND CHOLANGIORESONANCE IN PRIMARY SCLEROSING CHOLANGITIS: OUR EXPERIENCE

Roy López Grove, Florencia Vespa, Martina Aineseder, Alejandra Villamil, Juan Carlos Spina

Ann Hepatol. 2023;28 Supl 1:100904.143

Full text access

O-41 CIRRHOSIS IN PATIENTS WITH ALFA 1 ANTITRYPSIN DEFICIENCY; WHAT ARE WE MISSING?

Francisco Hevia, Daniela Hernández, Alfredo Mora, Ramsés Badilla, Natassia Camacho, Mildred Jiménez, Manuel Saborío, Karina Hidalgo, ... Danny Alvarado

Ann Hepatol. 2023;28 Supl 1:100904.144

Full text access

O-42 COSTA RICA NATIONAL NEWBORN SCREENING LABORATORY´S EXPERIENCE IN DIAGNOSING ALPHA-1 ANTITRYPSIN DEFICIENCY

Mariela Solano-Vargas, Juan Diego Gutiérrez-Ávila, Jessica Arroyo-Hernández, Danny Alvarado-Romero, Natassia Camacho-Matamoros, Mildred Jiménez-Hernández

Ann Hepatol. 2023;28 Supl 1:100904.145

Full text access

O-43 RISK FACTORS FOR CANCER DEVELOPMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS

Michelle Harriz Braga, Guilherme Grossi Lopes Cançado, Paulo Lisboa Bittencourt, Cláudia Alves Couto, Laura Vilar Guedes, André Mourão Costa Lima, Maria Lucia Gomes Ferraz, Cristiane Alves Villela-Nogueira, ... Eduardo Luiz Rachid Cançado

Ann Hepatol. 2023;28 Supl 1:100904.146

Full text access

OP-2 PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS ASSOCIATION WITH PHYSICAL ACTIVITY LEVELS AMONG ADULTS IN CHILE

Paulina Pettinelli, Tiziana Fernández, Carolina Aguirre, Francisco Barrera, Arnoldo Riquelme, Rodrigo Fernández-Verdejo

Ann Hepatol. 2023;28 Supl 1:100904.147

Full text access

OP-3 CLINICAL PRESENTATION AND CAUSATIVE AGENTS OF IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY IN URUGUAY: FIRST DECADE OF EXPERIENCE.

Nelia Hernandez, Daniela Chiodi, Adriana Sanchez, Laura Reyes, Ximena Pazos, María di Pace, Carla Bianchi, Yessica Pontet, ... María Isabel Lucena

Ann Hepatol. 2023;28 Supl 1:100904.148

Full text access

OP-4 IMPLEMENTATION OF A RE-LINKAGE TO CARE STRATEGY IN PATIENTS WITH CHRONIC HEPATITIS C WHO WERE LOST TO FOLLOW-UP IN LATIN AMERICA

Manuel Mendizabal, Marcos Thompson, Esteban Gonzalez-Ballerga, Margarita Anders, Graciela E Castro-Narro, Mario G Pessoa, Hugo Cheinquer, Gabriel Mezzano, ... Marcelo O Silva

Ann Hepatol. 2023;28 Supl 1:100904.149

Full text access

OP-5 ALCOHOL-ASSOCIATED HEPATITIS IN LATIN AMERICA: RESULTS FROM THE AH-LATIN STUDY

Luis Antonio Díaz, Jorge Arnold, Francisco Idalsoaga, Gustavo Ayares, María Ayala-Valverde, Diego Perez, Jaime Gomez, Rodrigo Escarate, ... Juan Pablo Arab

Ann Hepatol. 2023;28 Supl 1:100904.150

Full text access

Indexed in:

Follow us:

Indexed in:

Follow us:

Subscribe to our newsletter